Member login

Forgot Password?
Return to login
Better access to high quality biological medicines
The British Biosimilars Association (BBA) is the expert sector group of the British Generic Manufacturers Association (BGMA) exclusively focused on biosimilars

British Biosimilars Association (BBA) Stakeholder Forum, Tuesday, November 21. Click on the link below for a programme of events. (PDF download)

The British Biosimilars Association (BBA) is the expert sector group of the British Generic Manufacturers Association (BGMA) exclusively focused on biosimilars.

The members of the BBA ensure access to high quality, safe and effective biosimilar medicines for UK patients. As industry experts, we partner with patients’ representatives, healthcare professionals, regulators and payers to increase understanding and to drive a sustainable environment for the development, production and continuing optimised use of biosimilar medicines across the UK.

For more information about Biosimilars, please take a look at NHS England’s ‘What is a Biosimilar’ document.

Twitter

17.11.2017
Kavya Gopal appointed BBA chair https://t.co/uoJWVUDb78
17.11.2017
RT @PharmaReview: . @BritBiosimilars appoints new chair @Sandoz_Global #biosimilar https://t.co/OkLW9NHN1L RT
15.11.2017
@Sandoz_Global Kavya Gopal appointed chair of the British Biosimilars Assocation (BBA) - for further information see https://t.co/qfoaU8Z4YK
14.11.2017
BBA Stakeholder Forum Programme - Sharing success & challenges in biosimilars implementation. Last few places for our free event on November 21. Full programme here https://t.co/3j7tar37by Contact ania.swirski@instinctif.com
07.11.2017
On Nov 21, the British Biosimilars Association (BBA) will be staging its second annual conference sign up free here https://t.co/3pdPtYdLrz